Although mortality at 7 and 30 days was lower in the LD group, differences did not reach statistical significance, likely reflecting residual clinical frailty, comorbidities, or other unmodifiable prognostic factors.
← all excerpts
Impact of loading dose β-lactam therapy on outcomes of KPC-producing Klebsiella pneumoniae bloodstream infections in non-ICU patients: a real world study.
1
—
—